https://www.japantimes.co.jp/news/2022/10/02/national/science-health/kowa-ivermectin-covid-19/
The Nagoya-based company announced the results of its clinical trial, indicating it would no longer seek the drug's approval for COVID-19 treatment.
Create an account or login to join the discussion